Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 104177
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.104177
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.104177
Table 4 Logistic regression of risk factors for adverse perinatal outcomes
Measurement | β | SE | Wald | P value | Odd ratios | Unadjusted 95%CI | Adjusted 95%CI |
Constant | -11.302 | 9.945 | 1.292 | 0.256 | 0.000 | - | |
AGEs | 0.054 | 0.012 | 21.838 | 0.0001 | 1.056 | 8.562-169.764 | 1.032-1.080 |
sRAGE | -0.053 | 0.014 | 14.451 | 0.0001 | 0.949 | 0.012-0.150 | 0.923-0.975 |
SOD | -0.025 | 0.102 | 0.058 | 0.810 | 0.976 | 0.268-1.267 | 0.799-1.191 |
MDA | 0.113 | 0.552 | 0.042 | 0.838 | 1.119 | 1.461-7.553 | 0.380-3.299 |
- Citation: Zhang Y, Li T, Wang ZH, Liu Y. Correlation between serum advanced glycation end-products and their receptor-mediated oxidative stress and perinatal outcomes in gestational diabetes mellitus. World J Diabetes 2025; 16(6): 104177
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/104177.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.104177